| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/25/2008 | US7348154 fusion proteins comprising insulin-like growth factor binding protein-3 fragments of human native-sequence, linked to a synthetic polypetide, used in cell-based assays, as IGF antagonists, in mapping IGF binding sites on wild-type IGFBP-3 and IGF agonist peptides; KIRA phosphorylation |
| 03/25/2008 | US7348153 Administering a nonapeptide of amino acid sequence Leu-Leu-Val-Leu-Leu-Tyr-Ser-Lys-Leu or decapeptide of sequence Leu-Leu-Gln-Leu-Gly-Tyr-Ser-Gly-Arg-Leu comprising an HLA/human leukocyte antigen binding motif increase cytotoxic T lymphocytes (CTL) response to antigens |
| 03/25/2008 | US7348152 Using concentration of d-glactosides as diagnostic in detection of cancer; antitumor agents; immunoassay |
| 03/25/2008 | US7348151 Method for the cellular high-throughput-detection of nuclear receptor ligand interactions |
| 03/25/2008 | US7348147 Method and system for nucleic acid detection |
| 03/25/2008 | US7348144 Methods and system for multi-drug treatment discovery |
| 03/25/2008 | US7348143 Method of visualizing non-targeted metabolomic data generated from fourier transform ion cyclotron resonance mass spectrometers |
| 03/25/2008 | US7348141 For single nucleotide polymorphisms (SNPs) using fluorescently labelled oligonucleotide probes; solid phase synthesis |
| 03/25/2008 | US7348140 Clinical indications for genotyping polymorphic variants of G-protein coupled receptors |
| 03/25/2008 | US7348138 Diagnostic methods and kits for identifying individuals exposed to West Nile virus or other viruses including Flavivirus or Pestivirus |
| 03/25/2008 | US7348137 Determination of testosterone by mass spectrometry |
| 03/25/2008 | US7348136 Immunoglobulins specific to feline immunodeficiency virus envelope protein as a diagnostic indicator of RNA viral infection; immunodiagnostics; veterinary medicine |
| 03/25/2008 | US7348135 Assessing integrity of mitochondrial membrane via cyclic enzymatic reactions involving intra-mitochondrial compounds; identifying compounds which decrease membrane permeablity of mitochondria; screening microbiocides |
| 03/25/2008 | US7348010 Contains at least one peptide with a length of 9 to 25 amino acids and a sequence as occurs in extracellular doamin of HER-2/neu protein, and the peptide or functional variants conjugated to an immunogenic carrier |
| 03/25/2008 | US7348003 Tumor necrosis factor (TNF)-related apoptosis-inducing ligands; anticarcinogenic and antiproliferative agents; graft versus host disease, AIDS, neurodegenerative disorders |
| 03/25/2008 | US7348001 Protein that includes a heavy chain immunoglobulin variable domain sequence and a light chain immunoglobulin variable domain sequence; the protein ligand binds to Tie1 ectodomain, a receptor tyrosine kinase protein that includes a transmembrane domain; use in modulating angiogenesis |
| 03/25/2008 | US7347984 Mammalian agmatinase inhibitory substance |
| 03/25/2008 | US7347975 Bead dispensing system |
| 03/25/2008 | US7347974 Materials, method and apparatus for detection and monitoring of chemical species |
| 03/25/2008 | US7347973 determination chemical and biological constituents in bodily fluid; applying sample to test strips; storage results in computer |
| 03/25/2008 | US7347972 Multiple analyte assay device |
| 03/25/2008 | US7347971 Diagnostic test strip used to determine an analyte in a liquid |
| 03/25/2008 | US7347943 Methods and compositions for chromatography |
| 03/25/2008 | US7347926 Method and apparatus for measuring specific component |
| 03/25/2008 | US7347925 Biosensor for monitoring an analyte content with a partial voltage generated therefrom |
| 03/25/2008 | US7347825 Device and method for assessing asthma and other diseases |
| 03/25/2008 | US7347107 Device for a torque or shear force transmitter for the determination of fibre concentration or viscosity in pulp suspensions and method for resetting of the transmitter shaft in a torque or shear force transmitter |
| 03/25/2008 | US7347105 Method for the analysis of a test specimen of reducible material that contains iron |
| 03/25/2008 | CA2599771A1 Method for preparing agglutinatable platelet fragments and the use thereof |
| 03/25/2008 | CA2157202C Leuco dye coating compositions |
| 03/25/2008 | CA2115579C Ryegrass pollen allergen |
| 03/20/2008 | WO2008034071A2 Method of identifying patients suitable for high-dose cyclophosphamide treatment |
| 03/20/2008 | WO2008034016A2 Assays for detecting native-state proteins and identifying compounds that modulate the stability of native-state proteins |
| 03/20/2008 | WO2008033733A2 Integrated sample cell and filter and system using same |
| 03/20/2008 | WO2008033575A2 Methods of identifying biochemical pathways |
| 03/20/2008 | WO2008033540A2 Motion sickness reduction |
| 03/20/2008 | WO2008033535A2 Amine-reactive biosensor |
| 03/20/2008 | WO2008033473A2 Assay for the detection of phosphorylated pth |
| 03/20/2008 | WO2008033451A2 Protein aggregation domains from prions and methods of use thereof |
| 03/20/2008 | WO2008033368A2 Boroproline compound and cytokine combination therapy |
| 03/20/2008 | WO2008033239A2 Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof |
| 03/20/2008 | WO2008033164A1 Magnetic particle tagged reagents and techniques |
| 03/20/2008 | WO2008033090A1 A method of predicting the printability of a paper, or paper board |
| 03/20/2008 | WO2008033080A1 Methods for diagnosing a gastrointestinal disorder in an individual |
| 03/20/2008 | WO2008033074A1 Method and device for measuring liquid absorption |
| 03/20/2008 | WO2008033073A1 A method of determining analyte concentration |
| 03/20/2008 | WO2008033044A1 A method and preparations for the diagnosis and therapy of multiple sclerosis and immune demyelinating polyneuropathy |
| 03/20/2008 | WO2008032876A1 Preventive or remedy for er-negative and her2-negative breast cancer and method of screening the same |
| 03/20/2008 | WO2008032874A1 Method for screening for agent capable of controlling in vivo hypoxia-responsive system |
| 03/20/2008 | WO2008032868A1 Tumor marker for renal cancer and method for determination of occurrence of renal cancer |
| 03/20/2008 | WO2008032761A1 Detection marker for malignant tumor in urinary system, and detection kit and method for detection of malignant tumor in urinary system using the marker |
| 03/20/2008 | WO2008032760A1 Detection marker for cervical cancer, and detection kit and cervical cancer determination method using the marker |
| 03/20/2008 | WO2008032759A1 Detection marker for lung cancer, and detection kit and lung cancer determination method using the marker |
| 03/20/2008 | WO2008032712A1 Monoclonal antibody and use thereof |
| 03/20/2008 | WO2008032599A1 Semiconductor nanoparticle aggregate, process for producing the semiconductor nanoparticle aggregate, and biological substance labeling agent using the semiconductor nanoparticle aggregate |
| 03/20/2008 | WO2008032535A1 Fluorescent semiconductor microparticle, method for production of the microparticle, fluorescent labeling agent for biological substance using the microparticle, and bioimaging method using the microparticle |
| 03/20/2008 | WO2008032534A1 Fluorescent semiconductor microparticle assembly, fluorescent labeling agent assembly for biological substance, and bioimaging method and biological substance analysis method using the assemblies |
| 03/20/2008 | WO2008032323A2 Method of determining lymph node metastasis |
| 03/20/2008 | WO2008032265A1 Apparatus and method for well services fluid evaluation using x-rays |
| 03/20/2008 | WO2008032235A2 Methods for analysing protein samples based on the identification of c-terminal peptides |
| 03/20/2008 | WO2008032217A2 Method for investigating the response to a treatment with a monoclonal antibody |
| 03/20/2008 | WO2008032092A1 Method and kit for detecting if an individual is susceptible to progress to an active mycobacterial disease |
| 03/20/2008 | WO2008032084A1 Improved immunoassay methods |
| 03/20/2008 | WO2008032076A2 Biological fluid analysis system |
| 03/20/2008 | WO2008032073A2 Novel nematode protein and its use in producing anthelminthic agents and vaccines |
| 03/20/2008 | WO2008032066A1 Methods and devices for detecting structural changes in a molecule measuring electrochemical impedance |
| 03/20/2008 | WO2008031917A1 Biofluid metabolite profiling as a tool for early prediction of autoimmunity and type 1 diabetes risk |
| 03/20/2008 | WO2008031874A1 Determination of biological material ingredients |
| 03/20/2008 | WO2008031873A1 Methods of selecting cell clones |
| 03/20/2008 | WO2008031842A1 Inhibitors of gpr87 for cancer therapy |
| 03/20/2008 | WO2008031792A1 Component comprising a detection structure for mechanical damage |
| 03/20/2008 | WO2008031654A1 Sensor element for gas sensors and method for the operation thereof |
| 03/20/2008 | WO2008031641A1 Method for determining the ethanol content of the fuel in a motor vehicle |
| 03/20/2008 | WO2008031551A2 Non-neuroendocrine cancer therapy |
| 03/20/2008 | WO2008031532A1 Anti-drug antibody assay |
| 03/20/2008 | WO2008031453A1 Method and sensor for determining the passivating properties of a mixture containing at least two components, which are cement and water |
| 03/20/2008 | WO2008031437A2 Treatment of asthma, eczema and/or allergy using antibiotics |
| 03/20/2008 | WO2008031429A1 Method of diagnosing and monitoring the progress of multiple sclerosis, and the use of a test kit therefor |
| 03/20/2008 | WO2008031387A1 Eddy-current method for non-destructive quality control of mechanically hardened surfaces of austenitic steel tubes |
| 03/20/2008 | WO2008031288A1 Pre-filled centrifugal column for detecting hepatocellular carcinoma-specific alpha-fetoprotein variant and test kit containing the column |
| 03/20/2008 | WO2008031230A1 Methods of determining susceptibility of cells to reovirus infection and methods for treating cellular proliferative disorders with reovirus |
| 03/20/2008 | WO2008031226A1 Mammalian oocyte development competency granulosa markers and uses thereof |
| 03/20/2008 | WO2008031190A1 Alpha-1-antitrypsin as a diagnostic/prognostic indicator for neurodegenerative diseases |
| 03/20/2008 | WO2008031171A1 Pro-oxidant anti-cancer compounds |
| 03/20/2008 | WO2008031165A1 Methods and compositions for the diagnosis and treatment of tumours |
| 03/20/2008 | WO2008015419A3 Protein solubilisation |
| 03/20/2008 | WO2008013969A3 IMPROVED CELL-BASED FLUORESCENT ASSAYS FOR IDENTIFYING ALPHA AND DELTA ENaC MODULATORS |
| 03/20/2008 | WO2008009565A3 Method for screening an enhancer or a masker of salty taste |
| 03/20/2008 | WO2008008247A3 Near ultraviolet-wavelength photonic-crystal biosensor with enhanced surface to bulk sensitivity ratio |
| 03/20/2008 | WO2008006103A3 Nogo receptor functional motifs, peptide mimetics, and mutated functional motifs related thereto, and methods of using the same |
| 03/20/2008 | WO2008003656A3 Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics |
| 03/20/2008 | WO2008001357A3 Methods and kits for diagnosing cancer |
| 03/20/2008 | WO2007149486A3 Methods and materials for observing apoptosis by detecting fragments of clathrin-pathway components |
| 03/20/2008 | WO2007149407A3 Identification and characterization of analytes from whole blood |
| 03/20/2008 | WO2007149280A3 Recovery of analytes using combinatorial libraries |
| 03/20/2008 | WO2007148065A3 Antibody for anthrax |
| 03/20/2008 | WO2007145697A3 Directed-flow assay device |
| 03/20/2008 | WO2007143615A3 Systems and methods for performing measurements of one or more analytes comprising using magnetic particles and applying a magnetic field |
| 03/20/2008 | WO2007141043A3 Monoclonal anti-annexin a3 antibodies for the detection of prostate carcinoma |
| 03/20/2008 | WO2007140471A3 Ribosome and rna display of biologically active small molecules |